Abstract：Objective To investigate the correlation between serum adiponectin (APN) and cystatin C (CysC) on glucolipid metabolism in diabetic limb artery occlusion (DLAO). Methods From July 2017 to December 2018, 77 patients with the first stage or the second stage DLAO and 76 patients with diabetes mellitus (DM) admitted to Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine were selected as the study objects, named as DLAO group and DM group respectively. Body mass index (BMI), waist hip ratio (WHR) and serum total cholesterol (TC), triacylglycerol (TG), high-density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), CysC, APN levels were measured for all subjects. Logistic stepwise regression analysis with WHR, APN, CysC and Apo-A1 as independent variables was conducted for DLAO patients. Pearson correlation analysis was conducted between serum APN and BMI, WHR, course of diabetes, TC, TG, HbA1c, CysC. Results The levels of WHR and serum CysC in the DLAO group were significantly higher than those in the DM group. Serum APN and Apo-A1 in the DLAO group were significantly lower than those in the DM group, with statistically significant differences (all P ＜ 0.05). FBG, HbA1c, BMI, TC, TG, HDL-C, LDL-C and Apo-B of parents in the two groups showed no statistically significant differences (all P ＞ 0.05). Logistic stepwise regression analysis found that high serum APN was the independence protective factor for DLAO, while high serum CysC was the independence risk factor for DLAO (P ＜ 0.05). Pearson correlation analysis showed that serum APN level was negatively correlated with WHR, diabetes course, and serum CysC level (r ＜ 0, P ＜ 0.05), but not with BMI, TC, TG, and HbA1c (P ＞ 0.05). Conclusion Serum APN and CysC have a certain effect on glucolipid metabolism during the formation and development of DLAO.
[1] 班绎娟，冉兴无，杨川，等.中国部分省市糖尿病足病临床资料和住院费用等比较[J].中华糖尿病杂志，2014（7）：499-503.
[2] 任超，梁家立，张勇.脂联素对心血管保护作用的研究进展[J].实用医药杂志，2019，36（2）：169-171，176.
[3] 中国中西医结合学会周围血管疾病专业委员会.糖尿病肢体动脉闭塞症诊断及疗效标准（草案）[J].中国中西医结合外科杂志，2003，9（2）：150-151.
[4] 王儒.糖尿病防治新理念——解读《中国2型糖尿病防治指南（2017版）》[J].江苏卫生保健，2018（9）：14-16.
[5] Jensen T，Musaeus L，Molsing B，et al. process measures and outcome research as tools for future improvement of diabetes treatment quality[J]. Diabetes Res Clin Pract，2002，56（3）：207-211.
[6] 宫利平.血清 Apo-A1与Apo-B比值与青年女性进展型 缺血性脑卒中患者颈动脉粥样硬化发生率的关联性[J].内蒙古医学杂志，2018，50（3）：322-323.
[7] 熊红萍，李灿东，高碧珍，等.代谢综合征的中医证素与腹围、胰岛素抵抗的相关性研究[J].光明中医，2009，24（10）：1821-1823.
[8] Huxley R，Mendis S，Zhelenyakow E，et al. Body mass index，waist circumference and waist：hip ratio as predictors of cardiovascular risk-a review of the literature [J]. Eur J Clin Nutr，2010，64（1）：16-22.
[9] Bengtsson E，To F，Grubb A，et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice [J]. Atherosclerosis，2005，180（1）：45-53.
[10] Bengtsson E，Nilsson J，Jovinge S. Cystatin C and cathepsins in cardiovascular disease [J]. Front Biosci，2008，13：5780-5786.
[11] Liu F，Shen J，Zhao J，et al. Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? [J]. PLoS One，2013，8（7）：e66907.
[12] 白云，朱红艳，王海峰.2型糖尿病患者血清超敏C反应蛋白、胱抑素C的表达及其与血管病变程度相关性[J].实用临床医药杂志，2018，22（21）：52-54.
[13] 钟斌理.同型半胱氨酸、胱抑素C、超敏C反应蛋白、糖化血红蛋白与老年2型糖尿病颈动脉粥样硬化的相关性分析[J].糖尿病新世界，2018，21（24）：9-11.
[14] 晏丕军，张志红，徐勇，等.2型糖尿病患者血清胱抑素C水平与振动感觉阈值的关系[J].中南大学学报：医学版，2016，41（1）：58-64.
[15] 李娟，徐家新，王春，等.血清白细胞介素18、胱抑素C与2型糖尿病下肢血管病变的关系[J].蚌埠医学院学报，2019，44（3）：302-305.
[16] 丁玉兰，罗丽娅，魏在荣，等.2型糖尿病患者血清脂联素、25羟维生素D、血脂与下肢血管病变关系的研究[J].中国糖尿病杂志，2018，26（11）：885-889.
[17] Diniz TA， Aquino Júnior JCJ，Mosele FC，et al. Exercise-induced AMPK activation and IL-6 muscle production are disturbed in adiponectin knockout mice [J]. Cytokine，2019，119.
[18] 牛晓瑞，马建，赵娜.祛胰抵方对胰岛素抵抗3T3-L1脂肪细胞脂联素、瘦素及抵抗素表达的影响[J].河南中医，2019，39（4）：531-534.
[19] 窦爱华，惠威，刘梅，等.慢性肝病合并2型糖尿病的rs2943650位点变异及胰岛素抵抗之间的关系[J].临床肝胆病杂志，2018，34（11）：2379-2382.
[20] Zietz B，Buechler C，Kobuch K，et al. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2 [J]. Exp Clin Endocrinol Diabetes，2008，116（9）：552-536.
[21] 王莹，王爱华，田甜.2型糖尿病合并动脉粥样硬化中内皮素-1、脂联素、C反应蛋白的水平及相关代谢指标的相关性[J].广东医学，2019，40（7）：1020-1024.
[22] 石维，陈雷，卜瑞芳，等.2型糖尿病患者合并动脉粥样硬化危险因素分析[J].中国医药，2018，13（6）：879-881.
[23] 吴和弟，许丽娃，吉家钗，等.2型糖尿病合并冠心病患者血清PCT、hs-CRP及血脂水平与冠状动脉病变的关系分析[J].疑难病杂志，2018，17（10）：1094-1098.
[24] 刘虹宏，刘兆川，张京梅，等.尼可地尔对高龄2型糖尿病合并不稳定型心绞痛患者的疗效研究[J].中国医药，2018，13（12）：1782-1785.
[25] 张颖，魏显敬，郑振国，等.血清脂肪细胞因子水平与血管内皮功能及硬化程度的关系[J].海南医学，2018，29（10）：1352-1355.
2020, Vol. 17 
京公网安备 11010502046598号